Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia

Depression is highly prevalent in patients with schizophrenia and is associated with significant clinical consequences, but there is no known biomarker for depression in schizophrenia. One of the putative neurochemical biomarkers for depression in major depressive disorder (MDD) is reduced cerebral...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychopharmacology
Autori principali: Chiappelli, Joshua, Rowland, Laura M, Wijtenburg, S Andrea, Muellerklein, Florian, Tagamets, Malle, McMahon, Robert P, Gaston, Frank, Kochunov, Peter, Hong, L Elliot
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613604/
https://ncbi.nlm.nih.gov/pubmed/25722115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.57
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi